StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Medicenna Therapeutics's operating cash flow for the twelve months ending Mar 31, 2022 was -C$23.58M. For fiscal 2022 it was -C$23.58M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2022Mar 31, 2022-C$23.58M–
FY2021Mar 31, 2021-C$15.31M–
FY2020Mar 31, 2020-C$5.42M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ1 2023Mar 31, 2023-C$12.66M–
Q4 FY2022CQ1 2022Mar 31, 2022-C$23.58M–
Q4 FY2021CQ1 2021Mar 31, 2021-C$15.31M–

More Medicenna Therapeutics figures

See a number that looks wrong?